Blast­ing 'spec­u­la­tive com­men­tary,' GSK of­fers up­date on Zan­tac lit­i­ga­tion and vows to 'vig­or­ous­ly de­fend it­self'

3 years ago
Pharma
Law

No­var­tis re­ports two pa­tient deaths af­ter treat­ment with Zol­gens­ma

3 years ago
Pharma

As Covid pro­gram ad­vances, Enan­ta's new CMO says it's not 'lim­it­ed to an­tivi­ral­s'; With all eyes on Gilead-part­nered ...

3 years ago
Peer Review

Sanofi, GSK, Ha­le­on see stock prices dip and dive amid lit­i­ga­tion for re­called heart­burn drug

3 years ago
Pharma
Law

FDA con­verts No­var­tis' NSCLC drug to a full ap­proval with con­fir­ma­to­ry da­ta

3 years ago
Pharma

Bellde­grun-backed re­al es­tate de­vel­op­ment group blue­prints a new biotech cam­pus — this time in Boul­der

3 years ago
R&D

More than half a bil­lion Covid vac­cine dos­es wast­ed af­ter Emer­gen­t's Bal­ti­more fi­as­co

3 years ago
Coronavirus
Manufacturing

Astel­las an­nu­al can­cer prize goes to mo­bile re­port­ing app to bridge care gaps

3 years ago
Pharma
Marketing

Eli Lil­ly plucks a new com­mer­cial chief from Bris­tol My­ers in man­age­ment shuf­fle as HR chief re­tires

3 years ago
People
Pharma

Man­u­fac­tur­ing roundup: Mil­li­pore­Sig­ma launch­es new AAV plat­form; New IV flu­id man­u­fac­tur­ing fa­cil­i­ty is com­ing to ...

3 years ago
Manufacturing

FDA rais­es ques­tions with Eu­ro­pean da­ta law's re­stric­tions on re­view­ing clin­i­cal da­ta

3 years ago
Pharma
FDA+

Graphite Bio be­gins SCD cell ther­a­py tri­al; Syn­thet­ic Bi­o­log­ic­s' fu­ture rests on VCN ac­qui­si­tion

3 years ago
News Briefing

Sim­ba Gill heads back to Flag­ship af­ter sev­en-year run as Evelo CEO

3 years ago
People

Just months af­ter lay­offs and push­ing eye ther­a­py, Pro­QR to of­fload eye port­fo­lio in piv­ot to RNA-edit­ing

3 years ago
R&D

Fol­low­ing the re­cent play­book, Cin­Cor rais­es $225M on back of pos­i­tive PhII read­out

3 years ago
Financing
R&D

Ad­vent to sell stake in man­u­fac­tur­er and drug de­vel­op­er in a deal worth over $1B — re­port

3 years ago
Deals
Manufacturing

De­mand-con­strained Covid vac­cine mar­ket may push South Africa's As­pen to change its di­rec­tion

3 years ago
Coronavirus
Manufacturing

Amid Roche and Sanofi's oral SERD set­backs, Menar­i­ni gets speedy re­view at FDA

3 years ago
Pharma
FDA+

Cit­ing 'chal­leng­ing eco­nom­ic en­vi­ron­ment,' PhI­II-ready mi­cro­bio­me biotech lays off 20% of staffers

3 years ago
People

Cerev­el takes the pub­lic of­fer­ing route, with a twist — rais­ing big mon­ey thanks to ri­val da­ta

3 years ago
Financing

One year in­to clin­i­cal hold, FDA has more ques­tions about 'pooled' mi­cro­bio­me ther­a­py

3 years ago
FDA+

Pfiz­er launch­es re­bate pro­gram for rare dis­ease pa­tients who have to stop tak­ing Panzy­ga

3 years ago
Pharma

Hori­zon read­ies kids and fam­i­lies for back to school with week­long ac­tiv­i­ties around rare dis­ease cysti­nosis

3 years ago
Pharma
Marketing

EMA is­sues warn­ing of IVF drug short­age due to man­u­fac­tur­ing is­sues

3 years ago
Pharma
Manufacturing
First page Previous page 480481482483484485486 Next page Last page
A service from the Financial Times